Health Catalyst Inc (NASDAQ: HCAT) kicked off on Tuesday, up 1.21% from the previous trading day ,before settling in for the closing price of $6.60. Over the past 52 weeks, HCAT has traded in a range of $6.52-$14.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 21.79% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 113.27%. With a float of $55.71 million, this company’s outstanding shares have now reached $58.30 million.
In an organization with 1300 employees, it is important to assess its efficiency.
Health Catalyst Inc (HCAT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 4.87%, while institutional ownership is 86.86%. The most recent insider transaction that took place on Mar 15 ’24, was worth 15,648. In this transaction Chief People Officer of this company sold 2,005 shares at a rate of $7.80, taking the stock ownership to the 128,231 shares. Before that another transaction happened on Feb 27 ’24, when Company’s Chief Executive Officer bought 26,200 for $7.81, making the entire transaction worth $204,525. This insider now owns 1,172,623 shares in total.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/30/2023, the organization reported $0.02 earnings per share (EPS), higher than consensus estimate (set at $0) by $0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 113.27% per share during the next fiscal year.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Take a look at Health Catalyst Inc’s (HCAT) current performance indicators. Last quarter, stock had a quick ratio of 4.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Let’s dig in a bit further. During the last 5-days, its volume was 0.6 million. That was inferior than the volume of 0.61 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 7.95%. Additionally, its Average True Range was 0.36.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 3.27%, which indicates a significant decrease from 9.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.44% in the past 14 days, which was lower than the 61.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.50, while its 200-day Moving Average is $9.71. However, in the short run, Health Catalyst Inc’s stock first resistance to watch stands at $6.87. Second resistance stands at $7.05. The third major resistance level sits at $7.21. If the price goes on to break the first support level at $6.52, it is likely to go to the next support level at $6.36. Assuming the price breaks the second support level, the third support level stands at $6.18.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
The company with the Market Capitalisation of 391.18 million has total of 58,563K Shares Outstanding. Its annual sales at the moment are 295,940 K in contrast with the sum of -118,150 K annual income. Company’s last quarter sales were recorded 75,080 K and last quarter income was -30,310 K.
